Luke JJ - Search Results

1

Th2 Cells Are Associated with Tumor Recurrence Following Radiation.

Abdelhakiem MK, Bao R, Pifer PM, Molkentine D, Molkentine J, Hefner A, Beadle B, Heymach JV, Luke JJ, Ferris RL, Pickering CR, Wang JH, Patel RB, Skinner HD. Abdelhakiem MK, et al. Among authors: luke jj. Cancers (Basel). 2024 Apr 20;16(8):1586. doi: 10.3390/cancers16081586. Cancers (Basel). 2024. PMID: 38672668 Free PMC article.

2

Realizing the potential of plasma genotyping in an age of genotype-directed therapies.

Luke JJ, Oxnard GR, Paweletz CP, Camidge DR, Heymach JV, Solit DB, Johnson BE; Cell Free DNA Working Group. Luke JJ, et al. J Natl Cancer Inst. 2014 Aug 8;106(8):dju214. doi: 10.1093/jnci/dju214. Print 2014 Aug. J Natl Cancer Inst. 2014. PMID: 25106647 Free PMC article.

3

Clinical Response of a Patient to Anti-PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors.

Shah S, Ward JE, Bao R, Hall CR, Brockstein BE, Luke JJ. Shah S, et al. Among authors: luke jj. Cancer Immunol Res. 2016 Nov;4(11):903-909. doi: 10.1158/2326-6066.CIR-16-0087. Epub 2016 Sep 16. Cancer Immunol Res. 2016. PMID: 27638840 Free PMC article.

4

T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection.

Trujillo JA, Sweis RF, Bao R, Luke JJ. Trujillo JA, et al. Among authors: luke jj. Cancer Immunol Res. 2018 Sep;6(9):990-1000. doi: 10.1158/2326-6066.CIR-18-0277. Cancer Immunol Res. 2018. PMID: 30181337 Free PMC article.

5

Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.

Labadie BW, Bao R, Luke JJ. Labadie BW, et al. Among authors: luke jj. Clin Cancer Res. 2019 Mar 1;25(5):1462-1471. doi: 10.1158/1078-0432.CCR-18-2882. Epub 2018 Oct 30. Clin Cancer Res. 2019. PMID: 30377198 Free PMC article. Review.

6

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.

Luke JJ, Bao R, Sweis RF, Spranger S, Gajewski TF. Luke JJ, et al. Clin Cancer Res. 2019 May 15;25(10):3074-3083. doi: 10.1158/1078-0432.CCR-18-1942. Epub 2019 Jan 11. Clin Cancer Res. 2019. PMID: 30635339 Free PMC article.

7

BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.

Labadie BW, Liu P, Bao R, Crist M, Fernandes R, Ferreira L, Graupner S, Poklepovic AS, Duran I, Maleki Vareki S, Balar AV, Luke JJ. Labadie BW, et al. Among authors: luke jj. J Transl Med. 2019 Nov 25;17(1):386. doi: 10.1186/s12967-019-02144-7. J Transl Med. 2019. PMID: 31767020 Free PMC article.

8

PD-1 Blockade in Chinese versus Western Patients with Melanoma.

Shoushtari AN, Bao R, Luke JJ. Shoushtari AN, et al. Among authors: luke jj. Clin Cancer Res. 2020 Aug 15;26(16):4171-4173. doi: 10.1158/1078-0432.CCR-20-1558. Epub 2020 Jun 2. Clin Cancer Res. 2020. PMID: 32487680 Free PMC article.

9

ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.

Bao R, Hernandez K, Huang L, Luke JJ. Bao R, et al. Among authors: luke jj. J Immunother Cancer. 2020 Jul;8(2):e001020. doi: 10.1136/jitc-2020-001020. J Immunother Cancer. 2020. PMID: 32675312 Free PMC article.

10

Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types.

Bao R, Stapor D, Luke JJ. Bao R, et al. Among authors: luke jj. Genome Med. 2020 Oct 27;12(1):90. doi: 10.1186/s13073-020-00787-6. Genome Med. 2020. PMID: 33106165 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters